Nish Samantray
Co-Founder and Co-CFO
Arrae
Nish Samantray is the Co-founder and Co-CEO of Arrae, a science-backed wellness brand he launched in 2020 with his wife, Siffat Haider. Drawing on his background in operations and growth, and Siffat’s passion for holistic health, Nish helped lead Arrae from hand-packing orders to rapidly scaling the brand. Recognizing the power of natural solutions to address everyday wellness challenges—particularly those affecting women—Arrae is on a mission to make effective, accessible remedies for all.
Agios
Acrivon
Acrivon
3billion
- The future requires systems that connect data, models, and tools
- Salt AI platform enables companies to deploy, build, optimize, and run multi-model systems
- Proven impact in drug discovery with complex protein design pipeline
Dan Sheikh
VP, AI Solutions
Salt AI
Dan Sheikh is a technology strategist and AI innovator specializing in applying artificial intelligence and data science in regulated industries. With advanced degrees from University College London and the UCLA Anderson School of Management, he bridges deep technical expertise with strategic insight to design AI solutions that are powerful, compliant, and scalable. His work focuses on driving responsible digital transformation that aligns innovation with operational value and regulatory integrity.
Toby Sayre
VP, Business Development
Salt AI
Toby Sayre is a commercial leader with a background in life sciences and biotechnology consulting, business development, and product strategy. He holds master’s degrees in Cell and Molecular Biology and Biochemistry from San Francisco State University and UCLA. His work bridges bioinformatics, real-world data, and AI-driven software, integrating technical and commercial expertise to advance innovation in the life sciences.
Salt AI
Website: https://www.salt.ai/
- Salt AI is a contextual AI platform purpose-built for the life sciences. We connect data, models, and tools into a unified system that acts intelligently across the pharmaceutical, biotech, and healthcare value chain—transforming the way scientists and enterprises deploy and scale AI.
- Our platform makes the “black box” of enterprise AI transparent and interoperable, enabling seamless collaboration between specialized models and proprietary datasets. Salt’s native compute optimization ensures efficiency and performance—platform benchmarks show workloads like AlphaFold running up to 22× faster than out-of-the-box implementations.
- Designed for both technical and scientific users, Salt offers a visual-first, code-in/code-out interface that combines the flexibility of coding environments with the accessibility of low-code tools. Our engineering teams deploy Salt directly into customers’ preferred infrastructure and support solution development and rollout within 90 days.
- Salt AI is already driving real-world impact—recently accelerating the translation of oncology-focused computational proteins into the wet lab in partnership with the Ellison Medical Institute.
Bharath Takulapalli, PhD
Founder & CEO
SPOC Biosciences
Bharath is inventor of multiple foundational life science technologies at the interface of nanotechnology, systems biology and ML/AI, to extract 100x more information from systems biology than currently possible. He conceived Sensor-integrated Proteome On Chip (SPOC) technology to bridge a big gap in proteomics space, to democratize high-throughput functional protein screening. SPOC is the first and only technology that enables production of 1000s of full-length folded proteins on 1.5 sq-cm biosensor chips, to simultaneously screen for qualitative, quantitative, and kinetic information on protein bindings/interactions in a single assay, at once. Bharath is also the inventor of FENT solid-state nanopore technology for 1000x faster DNA sequencing at 1/10th cost, being developed by iNanoBio Inc. He raised $18M private capital and secured about $8M from DARPA, NIH. Bharath’s vision is to achieve 90% disease preemption, which is to detect and intervene in pre-disease phases, to cure before full disease onset.
Linnea Harnesk
Head of IP Legal
Autoliv